Task: Answer the multiple choice question.
Question: Which compound exhibits a 11.271\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) Cc1cc(C)c(C2=CC(=O)C[C@H](c3ccc4c(c3)OCO4)C2)c(C)c1
b.) CCc1nnc(NC(=O)CCc2nc(C3=CCN(C)CC3)no2)s1
c.) O=C(Nc1cc(C(=O)N2CCN(c3ccccc3O)CC2)ccc1Cl)c1cccs1
Answer: b. CCc1nnc(NC(=O)CCc2nc(C3=CCN(C)CC3)no2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nnc(NC(=O)CCc2nc(C3=CCN(C)CC3)no2)s1
CCc1nnc(NC(=O)CCc2nc(C3=CCN(C)CC3)no2)s1
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-[3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1,2,4-oxadiazol-5-yl]propanamide